DZ2548A1 - Compositions de sertraline solubilisée. - Google Patents

Compositions de sertraline solubilisée.

Info

Publication number
DZ2548A1
DZ2548A1 DZ980158A DZ980158A DZ2548A1 DZ 2548 A1 DZ2548 A1 DZ 2548A1 DZ 980158 A DZ980158 A DZ 980158A DZ 980158 A DZ980158 A DZ 980158A DZ 2548 A1 DZ2548 A1 DZ 2548A1
Authority
DZ
Algeria
Prior art keywords
compositions
solubilized
solubilized sertraline
sertraline compositions
sertraline
Prior art date
Application number
DZ980158A
Other languages
English (en)
Inventor
Dwayne Thomas Friesen
Scott Max Herbig
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971159&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DZ2548(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DZ2548A1 publication Critical patent/DZ2548A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DZ980158A 1997-07-01 1998-06-30 Compositions de sertraline solubilisée. DZ2548A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5141397P 1997-07-01 1997-07-01

Publications (1)

Publication Number Publication Date
DZ2548A1 true DZ2548A1 (fr) 2003-02-08

Family

ID=21971159

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ980158A DZ2548A1 (fr) 1997-07-01 1998-06-30 Compositions de sertraline solubilisée.

Country Status (34)

Country Link
EP (1) EP0999829A1 (fr)
JP (1) JP2000514100A (fr)
KR (1) KR100366373B1 (fr)
CN (1) CN1261794A (fr)
AP (1) AP1192A (fr)
AR (3) AR015917A1 (fr)
AU (1) AU742535B2 (fr)
BG (1) BG103918A (fr)
BR (1) BR9810739A (fr)
CA (1) CA2290974C (fr)
CO (1) CO4940495A1 (fr)
DZ (1) DZ2548A1 (fr)
EA (1) EA002481B1 (fr)
HN (1) HN1998000102A (fr)
HR (1) HRP980377A2 (fr)
HU (1) HUP0002236A3 (fr)
ID (1) ID23429A (fr)
IL (1) IL133076A (fr)
IS (1) IS5260A (fr)
MA (1) MA24587A1 (fr)
NO (1) NO996520L (fr)
OA (1) OA11243A (fr)
PA (1) PA8454301A1 (fr)
PE (1) PE97199A1 (fr)
PL (1) PL337804A1 (fr)
SK (1) SK181099A3 (fr)
TN (1) TNSN98124A1 (fr)
TR (1) TR199903297T2 (fr)
TW (1) TW550087B (fr)
UA (1) UA67741C2 (fr)
UY (1) UY25071A1 (fr)
WO (1) WO1999001120A1 (fr)
YU (1) YU68299A (fr)
ZA (1) ZA985708B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43702A (sh) 1999-12-23 2004-11-25 Pfizer Products Inc. Farmaceutske kompozicije koje obezbeđuju povećanje koncentracije leka
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
CA2420535A1 (fr) 2000-08-30 2002-03-07 Mary Tanya Am Ende Formulations a liberation prolongee pour les secretagogues de l'hormone de croissance
US20040191207A1 (en) * 2003-03-31 2004-09-30 Lipari John M. Alpha-hydroxy acid ester drug delivery compositions and methods of use
WO2008110268A1 (fr) * 2007-03-12 2008-09-18 Dsm Ip Assets B.V. Compositions cosmétiques
CA2771403C (fr) 2009-08-19 2015-02-24 Eisai R&D Management Co. Ltd. Composition pharmaceutique contenant un derive de quinoleine
WO2011081118A1 (fr) * 2009-12-29 2011-07-07 興和株式会社 Composition pharmaceutique pour administration orale
CN102711762A (zh) * 2009-12-29 2012-10-03 兴和株式会社 口服用固体医药组合物
CN109908354A (zh) * 2017-12-12 2019-06-21 万特制药(海南)有限公司 盐酸舍曲林口服浓缩液及其制备工艺
CN114894736B (zh) * 2022-05-20 2025-03-21 中化地质矿山总局地质研究院 一种氯化物型卤水中硝酸根的测定方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
DE69004529T2 (de) * 1989-08-30 1994-02-24 Pfizer Verwendung von Sertralin zur Behandlung von Abhängigkeiten von chemischen Stoffen.
ZA97976B (en) * 1996-04-05 1997-08-18 Alza Corp Uniform drug delivery theraphy.

Also Published As

Publication number Publication date
CN1261794A (zh) 2000-08-02
JP2000514100A (ja) 2000-10-24
PA8454301A1 (es) 2000-09-29
HUP0002236A2 (hu) 2003-08-28
EP0999829A1 (fr) 2000-05-17
AR040280A2 (es) 2005-03-23
NO996520D0 (no) 1999-12-28
AU742535B2 (en) 2002-01-03
IS5260A (is) 1999-11-19
IL133076A (en) 2003-12-10
EA002481B1 (ru) 2002-06-27
KR20010013365A (fr) 2001-02-26
NO996520L (no) 2000-02-29
TNSN98124A1 (fr) 2005-03-15
HN1998000102A (es) 1999-01-08
ZA985708B (en) 2000-01-10
UA67741C2 (uk) 2004-07-15
YU68299A (sh) 2002-06-19
CA2290974C (fr) 2004-04-27
SK181099A3 (en) 2000-07-11
OA11243A (en) 2003-07-24
PE97199A1 (es) 1999-10-05
WO1999001120A1 (fr) 1999-01-14
BG103918A (en) 2000-07-31
AP9801280A0 (en) 1998-06-30
CO4940495A1 (es) 2000-07-24
ID23429A (id) 2000-04-20
AP1192A (en) 2003-07-23
IL133076A0 (en) 2001-03-19
HRP980377A2 (en) 1999-04-30
KR100366373B1 (ko) 2003-01-14
TR199903297T2 (xx) 2000-07-21
TW550087B (en) 2003-09-01
UY25071A1 (es) 2000-12-29
EA199900962A1 (ru) 2000-08-28
BR9810739A (pt) 2000-09-12
PL337804A1 (en) 2000-09-11
MA24587A1 (fr) 1998-12-31
AR015917A1 (es) 2001-05-30
CA2290974A1 (fr) 1999-01-14
AU7544898A (en) 1999-01-25
AR040279A2 (es) 2005-03-23
HUP0002236A3 (en) 2003-12-29

Similar Documents

Publication Publication Date Title
TR199800375A3 (tr) Selant kompozisyonlari.
NO2006016I1 (no) 7,8,9,10-tetrahydro-6H-6,10-metanoazepinoÄ4,5-gÜkinoksalintartrat
PT993456E (pt) 4,5-diaril-imidazoles 2-substituidos
ID22931A (id) Komposisi-komposisi herbisidal
DE69815565D1 (de) Pestizide Zusammensetzungen
BR9711114A (pt) Composi-{es pesticidas
ID29241A (id) Turunan-turunan kinolin teranelasi-1,2
DE69919953D1 (de) Funktionelle zusammensetzungen
DK1298194T3 (da) Staniolholdige sammensætninger
ATE243416T1 (de) Pestizid-zusammensetzungen
DZ2205A1 (fr) Compositions antifongiques.
MA25306A1 (fr) Compositions de blanchiment.
TR199500796A2 (tr) Deterjan bilesimler.
ID25650A (id) Komposisi-komposisi sampo
IT1307041B1 (it) Composizione pesticida.
MA24305A1 (fr) Compositions de blanchiment.
ATE231685T1 (de) Pestizide zusammensetzungen
MA24587A1 (fr) Compositions de sertraline solubilisee
DK1149106T3 (da) 4,5-azolo-oxindoler
BR9903981B1 (pt) compostos e composiÇÕes de fragrancia de metilciclotetradec-5-en-1-onas.
MA24302A1 (fr) Compositions de blanchiment.
TR199700147A2 (tr) Mikrop öldürücü terkip.
MA24551A1 (fr) W.c.
TR199700041A2 (tr) Deterjan bilesimi.
MA24229A1 (fr) Composition detergente.